IRISanRaf

PIETROBONO, SILVIA

PIETROBONO, SILVIA  

Dipartimento di Scienze Umane e Promozione della Qualità della Vita  

Mostra records
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autore(i) File
A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib 1-gen-2021 Pietrobono, Silvia; Melisi, Davide
Aberrant sialylation in cancer: Biomarker and potential target for therapeutic intervention? 1-gen-2021 Pietrobono, S.; Stecca, B.
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resistance to TGFb Inhibition in Pancreatic Ductal Adenocarcinoma 1-gen-2024 Pietrobono, S.; Sabbadini, F.; Bertolini, M.; Mangiameli, D.; De Vita, V.; Fazzini, F.; Lunardi, G.; Casalino, S.; Scarlato, E.; Merz, V.; Zecchetto, C.; Quinzii, A.; Conza, G. D.; Lahn, M.; Melisi, D.
CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages 1-gen-2024 Pietrobono, Silvia; Bertolini, Monica; De Vita, Veronica; Sabbadini, Fabio; Fazzini, Federica; Frusteri, Cristina; Scarlato, Enza; Mangiameli, Domenico; Quinzii, Alberto; Casalino, Simona; Zecchetto, Camilla; Merz, Valeria; Melisi, Davide
Circumventing human limits in precision oncology: AI-enhanced tailoring of post-operative treatment for pancreatic ductal adenocarcinoma 1-gen-2024 Casalino, S; Zecchetto, C; Merz, V; Quinzii, A; Pietrobono, S; Melisi, D
Clinical Response to Futibatinib in Patients with High-Level FGFR2-Amplified Advanced Gastric Cancer: Two Case Reports 1-gen-2022 Quinzii, Alberto; Zecchetto, Camilla; Casalino, Simona; Gaule, Marina; Pesoni, Camilla; Merz, Valeria; Contarelli, Serena; Pietrobono, Silvia; Benhadji, Karim A; Melisi, Davide
Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma 1-gen-2023 Pietrobono, S; Stecca, B.
Down-Regulation of SOX2 Underlies the Inhibitory Effects of the Triphenylmethane Gentian Violet on Melanoma Cell Self-Renewal and Survival 1-gen-2016 Pietrobono, S.; Morandi, A.; Gagliardi, S.; Gerlini, G.; Borgognoni, L.; Chiarugi, P.; Arbiser, J. L.; Stecca, B.
Exceptional Clinical Response to Alectinib in Pancreatic Acinar Cell Carcinoma With a Novel ALK-KANK4 Gene Fusion 1-gen-2022 Gaule, M.; Pesoni, C.; Quinzii, A.; Zecchetto, C.; Casalino, S.; Merz, V.; Contarelli, S.; Pietrobono, S.; Vissio, E.; Molinaro, L.; Manzin, E.; Volpatto, R.; Vellani, G.; Melisi, D.
Injectable Thermogelling Nanostructured Ink as Simultaneous Optical and Magnetic Resonance Imaging Contrast Agent for Image-Guided Surgery 1-gen-2024 Cressoni, Chiara; Malandra, Sarah; Milan, Emil; Boschi, Federico; Nicolato, Elena; Negri, Alessandro; Veccia, Alessandro; Bontempi, Pietro; Mangiameli, Domenico; Pietrobono, Silvia; Melisi, Davide; Marzola, Pasquina; Antonelli, Alessandro; Speghini, Adolfo
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear 1-gen-2024 Melisi, Davide; Casalino, Simona; Pietrobono, Silvia; Quinzii, Alberto; Zecchetto, Camilla; Merz, Valeria
Mapk15 controls hedgehog signaling in medulloblastoma cells by regulating primary ciliogenesis 1-gen-2021 Pietrobono, S.; Franci, L.; Imperatore, F.; Zanini, C.; Stecca, B.; Chiariello, M.
Non-canonical hedgehog signaling pathway in cancer: Activation of GLI transcription factors beyond smoothened 1-gen-2019 Pietrobono, S.; Gagliardi, S.; Stecca, B.
p38 MAPK-dependent phosphorylation of transcription factor SOX2 promotes an adaptive response to BRAF inhibitors in melanoma cells 1-gen-2022 Pietrobono, Silvia; De Paolo, Raffaella; Mangiameli, Domenico; Marranci, Andrea; Battisti, Ilaria; Franchin, Cinzia; Arrigoni, Giorgio; Melisi, Davide; Poliseno, Laura; Stecca, Barbara
Perioperative NALIRIFOX in patients with resectable pancreatic ductal adenocarcinoma: The open-label, multicenter, phase II nITRO trial 1-gen-2024 Melisi, Davide; Zecchetto, Camilla; Merz, Valeria; Malleo, Giuseppe; Landoni, Luca; Quinzii, Alberto; Casalino, Simona; Fazzini, Federica; Gaule, Marina; Pesoni, Camilla; Casetti, Luca; Esposito, Alessandro; Marchegiani, Giovanni; Piazzola, Cristiana; D'Onofrio, Mirko; de Robertis, Riccardo; Gabbrielli, Armando; Bernardoni, Laura; Crino, Stefano F; Pietrobono, Silvia; Luchini, Claudio; Aliberti, Camillo; Martignoni, Guido; Milleri, Stefano; Butturini, Giovanni; Scarpa, Aldo; Salvia, Roberto; Bassi, Claudio
Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer 1-gen-2022 Merz, Valeria; Mangiameli, Domenico; Zecchetto, Camilla; Quinzii, Alberto; Pietrobono, Silvia; Messina, Carlo; Casalino, Simona; Gaule, Marina; Pesoni, Camilla; Vitale, Pasquale; Trentin, Chiara; Frisinghelli, Michela; Melisi., Orazio Caffo and Davide
Regulation of melanoma initiating cells by Hedgehog signaling and SOX2 1-gen-2014 Santini, R; Pandolfi, S; Montagnani, V; Pietrobono, S; Pimpinelli, N; Borgognoni, L; Stecca, B
Soft tissue sarcoma cancer stem cells: An overview 1-gen-2018 Genadry, K. C.; Pietrobono, S.; Rota, R.; Linardic, C. M.
SOX2 as a novel contributor of oxidative metabolism in melanoma cells 1-gen-2018 Andreucci, E.; Pietrobono, S.; Peppicelli, S.; Ruzzolini, J.; Bianchini, F.; Biagioni, A.; Stecca, B.; Calorini, L.
SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells 1-gen-2014 Santini, R.; Pietrobono, S.; Pandolfi, S.; Montagnani, V.; D'Amico, M.; Penachioni, J. Y.; Vinci, M. C.; Borgognoni, L.; Stecca, B.